Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Josiassen

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Critical Care|April 30, 2021
Interventional treatment of acute myocardial infarction-related cardiogenic shockJakob Josiassen, Jacob E Møller, Lene Holmvang, et al.
Kardiologia Polska|July 22, 2021
Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock: a systematic review of used cardiogenic shock definitions and outcomesJakob Josiassen, Martin Frydland, Christian Hassager, et al.
European Heart Journal. Acute Cardiovascular Care|May 13, 2025
Diabetes in resuscitated comatose out-of-hospital cardiac arrest patients - A substudy of the randomized BOX trialJakob Josiassen, Jacob E Møller, Henrik Schmidt, et al.
Anesthesiology|October 23, 2015
Oral Midodrine Hydrochloride for Prevention of Orthostatic Hypotension during Early Mobilization after Hip Arthroplasty: A Randomized, Double-blind, Placebo-controlled TrialØivind Jans, Jesper Mehlsen, Per Kjærsgaard-Andersen, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarctionJakob Josiassen, Ole Kristian L Helgestad, Jacob E Møller, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 14, 2021
Admission biomarkers among patients with acute myocardial-infarction related cardiogenic shock with or without out-of-hospital cardiac arrest an exploratory studyMichael Thøgersen, Martin Frydland, Ole Kristian Lerche Helgestad, et al.
European Heart Journal. Acute Cardiovascular Care|May 19, 2020
Prognostic importance of culprit lesion location in cardiogenic shock due to myocardial infarctionJakob Josiassen, Ole Kl Helgestad, Jacob E Møller, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 11, 2020
Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activationJakob Josiassen, Martin Frydland, Lene Holmvang, et al.
European Heart Journal. Acute Cardiovascular Care|May 27, 2020
The association of diabetes and admission blood glucose with 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shockMichael Thoegersen, Jakob Josiassen, Ole Kl Helgestad, et al.
European Heart Journal. Acute Cardiovascular Care|January 10, 2025
Association between haemolysis markers and neuron-specific enolase in acute myocardial infarction complicated by cardiogenic shock patients supported with a microaxial flow pumpZakaria Alaoui-Ismaili, Anika Klein, Jakob Josiassen, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Critical Care|April 30, 2021
Interventional treatment of acute myocardial infarction-related cardiogenic shockJakob Josiassen, Jacob E Møller, Lene Holmvang, et al.
Kardiologia Polska|July 22, 2021
Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock: a systematic review of used cardiogenic shock definitions and outcomesJakob Josiassen, Martin Frydland, Christian Hassager, et al.
European Heart Journal. Acute Cardiovascular Care|May 13, 2025
Diabetes in resuscitated comatose out-of-hospital cardiac arrest patients - A substudy of the randomized BOX trialJakob Josiassen, Jacob E Møller, Henrik Schmidt, et al.
Anesthesiology|October 23, 2015
Oral Midodrine Hydrochloride for Prevention of Orthostatic Hypotension during Early Mobilization after Hip Arthroplasty: A Randomized, Double-blind, Placebo-controlled TrialØivind Jans, Jesper Mehlsen, Per Kjærsgaard-Andersen, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarctionJakob Josiassen, Ole Kristian L Helgestad, Jacob E Møller, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 14, 2021
Admission biomarkers among patients with acute myocardial-infarction related cardiogenic shock with or without out-of-hospital cardiac arrest an exploratory studyMichael Thøgersen, Martin Frydland, Ole Kristian Lerche Helgestad, et al.
European Heart Journal. Acute Cardiovascular Care|May 19, 2020
Prognostic importance of culprit lesion location in cardiogenic shock due to myocardial infarctionJakob Josiassen, Ole Kl Helgestad, Jacob E Møller, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 11, 2020
Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activationJakob Josiassen, Martin Frydland, Lene Holmvang, et al.
European Heart Journal. Acute Cardiovascular Care|May 27, 2020
The association of diabetes and admission blood glucose with 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shockMichael Thoegersen, Jakob Josiassen, Ole Kl Helgestad, et al.
European Heart Journal. Acute Cardiovascular Care|January 10, 2025
Association between haemolysis markers and neuron-specific enolase in acute myocardial infarction complicated by cardiogenic shock patients supported with a microaxial flow pumpZakaria Alaoui-Ismaili, Anika Klein, Jakob Josiassen, et al.
Pageof 5